292 related articles for article (PubMed ID: 30854032)
21. Role of Truncated
Pinto D; Parameswaran R
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444377
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
[TBL] [Abstract][Full Text] [Related]
23. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
24. Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.
Tang H; Partyka K; Hsueh P; Sinha JY; Kletter D; Zeh H; Huang Y; Brand RE; Haab BB
Cell Mol Gastroenterol Hepatol; 2016 Feb; 2(2):201-221.e15. PubMed ID: 26998508
[TBL] [Abstract][Full Text] [Related]
25. Cancer snap-shots: Biochemistry and glycopathology of O-glycans: A review.
Sanji AS; J M; Gurav MJ; Batra SK; Chachadi VB
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129318. PubMed ID: 38232866
[TBL] [Abstract][Full Text] [Related]
26. Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin.
Rømer TB; Aasted MKM; Dabelsteen S; Groen A; Schnabel J; Tan E; Pedersen JW; Haue AD; Wandall HH
Br J Cancer; 2021 Oct; 125(9):1239-1250. PubMed ID: 34526666
[TBL] [Abstract][Full Text] [Related]
27. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.
Loureiro LR; Sousa DP; Ferreira D; Chai W; Lima L; Pereira C; Lopes CB; Correia VG; Silva LM; Li C; Santos LL; Ferreira JA; Barbas A; Palma AS; Novo C; Videira PA
Sci Rep; 2018 Aug; 8(1):12196. PubMed ID: 30111774
[TBL] [Abstract][Full Text] [Related]
28. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
29. Role of tumour markers, cytogenetics.
Lamerz R
Ann Oncol; 1999; 10 Suppl 4():145-9. PubMed ID: 10436809
[TBL] [Abstract][Full Text] [Related]
30. Glycosylation: Rising Potential for Prostate Cancer Evaluation.
Kałuża A; Szczykutowicz J; Ferens-Sieczkowska M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359624
[TBL] [Abstract][Full Text] [Related]
31. PSGL-1 from the murine leukocytic cell line WEHI-3 is enriched for core 2-based O-glycans with sialyl Lewis x antigen.
Kawar ZS; Johnson TK; Natunen S; Lowe JB; Cummings RD
Glycobiology; 2008 Jun; 18(6):441-6. PubMed ID: 18310305
[TBL] [Abstract][Full Text] [Related]
32. Novel glycan biomarkers for the detection of lung cancer.
Arnold JN; Saldova R; Galligan MC; Murphy TB; Mimura-Kimura Y; Telford JE; Godwin AK; Rudd PM
J Proteome Res; 2011 Apr; 10(4):1755-64. PubMed ID: 21214223
[TBL] [Abstract][Full Text] [Related]
33. Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states.
Peracaula R; Royle L; Tabares G; Mallorqui-Fernández G; Barrabés S; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
Glycobiology; 2003 Apr; 13(4):227-44. PubMed ID: 12626415
[TBL] [Abstract][Full Text] [Related]
34. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
[TBL] [Abstract][Full Text] [Related]
35. O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype.
Freitas D; Campos D; Gomes J; Pinto F; Macedo JA; Matos R; Mereiter S; Pinto MT; Polónia A; Gartner F; Magalhães A; Reis CA
EBioMedicine; 2019 Feb; 40():349-362. PubMed ID: 30662000
[TBL] [Abstract][Full Text] [Related]
36. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays.
Rho JH; Mead JR; Wright WS; Brenner DE; Stave JW; Gildersleeve JC; Lampe PD
J Proteomics; 2014 Jan; 96():291-9. PubMed ID: 24185138
[TBL] [Abstract][Full Text] [Related]
37. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of N-glycans from human alfa-acid-glycoprotein using stable isotope labeling and zwitterionic hydrophilic interaction capillary liquid chromatography electrospray mass spectrometry as tool for pancreatic disease diagnosis.
Giménez E; Balmaña M; Figueras J; Fort E; Bolós C; Sanz-Nebot V; Peracaula R; Rizzi A
Anal Chim Acta; 2015 Mar; 866():59-68. PubMed ID: 25732693
[TBL] [Abstract][Full Text] [Related]
39. Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans.
Mare L; Trinchera M
Eur J Biochem; 2004 Jan; 271(1):186-94. PubMed ID: 14686931
[TBL] [Abstract][Full Text] [Related]
40. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
